Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic neurological disorder characterized by the association of hypomyelinating leukodystrophy with spondylometaphyseal dysplasia. Patients present in infancy with absent or delayed ability to walk independently, slowly progressive motor deterioration, spasticity, ataxia, proximal weakness, and joint contractures. Additional manifestations include mild cognitive impairment, short stature, scoliosis, enlarged and deformed joints, dysarthria, nystagmus, visual defects, and mildly dysmorphic features, among others. Mode of inheritance is X-linked recessive.
Features include always present findings: Delayed CNS myelination, Short stature, Ataxia, and Flattened epiphysis and others; and common findings: Babinski sign. 49 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 7 | Skeletal muscle atrophy, Kyphoscoliosis, Delayed skeletal maturation |
Brain and nerves | 6 | Seizure, Ataxia, Intellectual disability |
Muscles | 2 | Flexion contracture, Skeletal muscle atrophy |
Head and neck | 2 | Coarse facial features, High palate |
Arms and legs | 2 | Short finger, Broad foot |
Eyes | 2 | Nystagmus, Optic disc pallor |
Growth and development | 1 | Short stature |
Heart and blood vessels | 1 | Widened subarachnoid space |
Age of onset: childhood.
AIFM1 encodes apoptosis inducing factor mitochondria associated 1 (613 aa). Functions both as NADH oxidoreductase and as regulator of apoptosis. Highest expression in Adrenal Gland (62.8 TPM) and Cells EBV-transformed lymphocytes (58.3 TPM).
Spondyloepimetaphyseal dysplasia, Bieganski type is associated with mutations in the AIFM1 gene on chromosome X.
AIFM1 is classified as a druggable target (Druggable Genome category) with score 5.2.
Genetic testing for AIFM1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spondyloepimetaphyseal dysplasia, Bieganski type has been reported in the published literature.
Phenotype severity distribution: 15 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spondyloepimetaphyseal dysplasia, Bieganski type.
234 publications have been identified in PubMed for spondyloepimetaphyseal dysplasia, Bieganski type. Research spans Review / Meta-Analysis (71%), Basic Science / Preclinical (12%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 147 | 71% |
Laboratory research | 25 | 12% |
Patient case studies | 17 | 8% |
Disease patterns and progression | 10 | 5% |
Testing and diagnosis research | 3 | 1% |
Other research | 2 | 1% |
Clinical study results | 2 | 1% |
New treatment approaches | 1 | 0% |
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Epidemiology / Natural History]
Puac-Polanco P (2026). [PMID: 42399018](https://pubmed.ncbi.nlm.nih.gov/42399018/). *Neuroimaging Clin N Am*. [Review / Meta-Analysis]
Wu D (2026). [PMID: 41072814](https://pubmed.ncbi.nlm.nih.gov/41072814/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Elsherbini A (2026). [PMID: 41689580](https://pubmed.ncbi.nlm.nih.gov/41689580/). *J Hand Surg Am*. [Review / Meta-Analysis]
Di Girolamo D (2026). [PMID: 41445194](https://pubmed.ncbi.nlm.nih.gov/41445194/). *Mol Ther*. [Basic Science / Preclinical]
Yadlapati S (2026). [PMID: 35201722](https://pubmed.ncbi.nlm.nih.gov/35201722/). *Unknown Journal*. [Basic Science / Preclinical]
Creignou M (2026). [PMID: 41651099](https://pubmed.ncbi.nlm.nih.gov/41651099/). *Semin Cancer Biol*. [Review / Meta-Analysis]
Volkert D (2026). [PMID: 42045693](https://pubmed.ncbi.nlm.nih.gov/42045693/). *Z Gerontol Geriatr*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41873429](https://pubmed.ncbi.nlm.nih.gov/41873429/). *Hum Reprod Open*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 3:08 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center